If you read our SEC filings you would know the firm has barely sold any of the series C.
Dilution isn't a concern as the firm can always buy back stock in a few years when we're bringing billions in revenue from Sawston. Merck went over 2B shares and has been buying back stock using Keytruda revenue. We could easily do the same.
Did you know that Sawston can store around $60B in frozen DCVax doses? Very little focus on the immense foresight Linda Powers put into manufacturing capacity planning at Sawston.
Market Data 
Markets 
AI
